Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Berta Otová

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Procedures

Neoplasm Transplantation

Anatomy

Concepts & Ideas

Time Factors

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
20
Holý, Antonín
19
Votruba, Ivan
16
Sladká, M
12
Kren, Vladimír
11
Panczak, A
9
Schramlová, Jana
7
Bílá, Vlasta
7
Blazek, K
6
Mandys, Václav
5
Marinov, I
4
Krenová, Drahomíra
4
Holy, Antonin
4
Zídek, Zdenek
3
Bartácková, M
3
Franková, D

Sign-in to see all Coauthors

Publications

TOP 3
Otová Berta; Hrdy Jirí; Votruba Ivan; Holy Antonín
In vivo modulation of angiogenic gene expression by acyclic nucleoside phosphonates PMEDAP and PMEG.
Zápotocký M; Hanzalová J; Starková J; Votruba I; Holý A; Otová B
Experimental therapy with 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): origin of resistance.
Otová Berta; Václavíková Radka; Danielová Vlasta; Holubová Jaroslava; Ehrlichová Marie; Horský Stanislav; Soucek Pavel; Simek Petr; Gut Ivan
Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Berta Otová (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Otová Berta; Hrdy Jirí; Votruba Ivan; Holy Antonín
In vivo modulation of angiogenic gene expression by acyclic nucleoside phosphonates PMEDAP and PMEG.
Anticancer research 2009;29(4):1295-302.
2007: Zápotocký M; Hanzalová J; Starková J; Votruba I; Holý A; Otová B
Experimental therapy with 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): origin of resistance.
Folia biologica 2007;53(3):79-84.
2006: Otová Berta; Václavíková Radka; Danielová Vlasta; Holubová Jaroslava; Ehrlichová Marie; Horský Stanislav; Soucek Pavel; Simek Petr; Gut Ivan
Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2006;29(5):442-50.
2005: Votruba Ivan; Pomeisl Karel; Tloust'ová Eva; Holý Antonín; Otová Berta
Inhibition of thymidine phosphorylase (PD-ECGF) from SD-lymphoma by phosphonomethoxyalkyl thymines.
Biochemical pharmacology 2005;69(10):1517-21.
2003: Valeriánová Marie; Otová Berta; Bílá Vlasta; Hanzalová Jitka; Votruba Ivan; Holý Antonín; Eckschlager Tomás; Krejcí Ondrej; Trka Jan
PMEDAP and its N6-substituted derivatives: genotoxic effect and apoptosis in in vitro conditions.
Anticancer research 2003;23(6C):4933-9.
2003: Madzo Jozef; Zuna Jan; Muzíková Katerina; Kalinová Markéta; Krejcí Ondrej; Hrusák Ondrej; Otová Berta; Starý Jan; Trka Jan
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Cancer 2003;97(1):105-13.
2002: Birkus Gabriel; Hájek Miroslav; Kramata Pavel; Votruba Ivan; Holý Antonín; Otová Berta
Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon*.
Antimicrobial agents and chemotherapy 2002;46(5):1610-3.
2002: Otová B; Sladká M; Damoiseaux J; Panczak A; Mandys V; Marinov I
Relevant animal model of human lymphoblastic leukaemia/lymphoma--spontaneous T-cell lymphomas in an inbred Sprague-Dawley rat strain (SD/Cub).
Folia biologica 2002;48(6):213-26.
2001: Holý A; Otová B; Budesínský M; Emerson D; Wiles M E
O-Phosphonatomethylcholine, its analogues, alkyl esters, and their biological activity.
Journal of medicinal chemistry 2001;44(25):4462-7.
2001: Bobkov K; Gut I; Mandys V; Holý A; Votruba I; Otová B
Antitumour activity of a combined treatment with PMEDAP and docetaxel in the Prague inbred Sprague-Dawley/cub rat strain bearing T-cell lymphoma.
Anticancer research 2001;21(4A):2725-31.
2001: Valeriánová M; Votruba I; Holy A; Mandys V; Otová B
Antitumour activity of N6-substituted PMEDAP derivatives against T-cell lymphoma.
Anticancer research 2001;21(3B):2057-64.
2001: Strestíková P; Otová B; Filipec M; Masek K; Farghali H
Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A.
Immunopharmacology and immunotoxicology 2001;23(1):67-74.
2000: Bobková K; Otová B; Marinov I; Mandys V; Panczak A; Votruba I; Holý A
Anticancer effect of PMEDAP--monitoring of apoptosis.
Anticancer research 2000;20(2A):1041-7.
2000: Strestíková P; Otová B; Filipec M; Farghali H
Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages.
Physiological research / Academia Scientiarum Bohemoslovaca 2000;49(6):725-8.
1999: Birkus G; Votruba I; Holý A; Otová B
9-[2-(Phosphonomethoxy)ethyl]adenine diphosphate (PMEApp) as a substrate toward replicative DNA polymerases alpha, delta, epsilon, and epsilon*.
Biochemical pharmacology 1999;58(3):487-92.
1999: Otová B; Francová K; Franek F; Koutník P; Votruba I; Holy A; Sladká M; Schramlová J
9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP)--a potential drug against hematological malignancies--induces apoptosis.
Anticancer research 1999;19(4B):3173-82.
1999: Otová B; Sladká M; Damoiseaux J; Panczak A; Mandys V; Francová K; Kudlácková M
Characterization of T-cell lymphomas in the Prague inbred Sprague-Dawley/cub rat strain: a model of spontaneous hematologic malignancy.
Transplantation proceedings 1999;31(3):1618-9.
1999: Panczak A; Kren V; Bílá V; Pravenec M; Matousková M; Krenová D; Otová B; Sladká M
Graft-versus-host disease in the rat: a genetic analysis in recombinant inbred strains of SHR x BN. Lx and BN. Lx x SHR sets.
Transplantation proceedings 1999;31(3):1569-70.
1999: Otová B; Mráz M; Mandys V; Panczak A; Schramlová J; Votruba I; Holy A
Therapeutic effect of heat shock on T-cell lymphoma in inbred Sprague-Dawley rat.
Folia biologica 1999;45(4):121-31.
1998: Sladká M; Otová B
Cytogenetic changes in Sprague-Dawley rat lymphomas in the course of in vivo passages.
Folia biologica 1998;44(4):143-50.
1997: Otová B; Sladká M; Panczak A; Marinov I
Biological characteristics of spontaneous transplantable T-cell lymphomas in inbred Sprague-Dawley/cub rats.
Transplantation proceedings 1997;29(3):1754-5.
1997: Otová B; Panczak A; Kohoutová M; Blazek K; Schramlová J; Sladká M; Holý A
Inhibition of acute graft-versus-host disease in (LEW.1W x LEW.1A)F1 rats using 9-(2-phosphonomethoxyethyl)-2,6-diaminopurine.
Transplantation proceedings 1997;29(3):1736-7.
1997: Panczak A; Bílá V; Sladká M; Krenová D; Otová B; Pravenec M; Kren V
Genetic analysis of graft-versus-host disease using rat recombinant inbred strains.
Transplantation proceedings 1997;29(3):1734-5.
1997: Otová B; Zídek Z; Holý A; Votruba I; Sladká M; Marinov I; Lesková V
Antitumor activity of novel purine acyclic nucleotide analogs PMEA and PMEDAP.
In vivo (Athens, Greece) 1997;11(2):163-7.
1997: Otová B; Holý A; Votruba I; Sladká M; Bílá V; Mejsnarová B; Lesková V
Genotoxicity of purine acyclic nucleotide analogs.
Folia biologica 1997;43(6):225-9.
1997: Schramlová J; Blazek K; Otová B; Bartácková M; Hulínská D
The effect of an antiphlogistic incorporated in liposomes on experimentally induced inflammation.
Folia biologica 1997;43(5):195-9.
1997: Schramlová J; Blazek K; Bartácková M; Otová B; Mardesicová L; Zizkovský V; Hulínská D
Electron microscopic demonstration of the penetration of liposomes through skin.
Folia biologica 1997;43(4):165-9.
1997: Schramlová J; Blazek K; Danielová V; Bartácková M; Holubová J; Otová B; Hulínská D
Electron microscopic demonstration of the interaction of liposomes and cells in vitro.
Folia biologica 1997;43(4):161-4.
1997: Otová B; Panczak A; Símová J; Jandlová T; Bubeník J; Blazek K; Schramlová J; Marinov I
Treatment of transplanted spontaneous rat T-cell leukaemia with local administration of recombinant murine interleukin-2.
Folia biologica 1997;43(1):25-32.
1996: Kramata P; Votruba I; Otová B; Holý A
Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
Molecular pharmacology 1996;49(6):1005-11.
1995: Zídek A; Holý A; Franková D; Otová B
Suppression of rat adjuvant arthritis by some acyclic nucleotide analogs.
European journal of pharmacology 1995;286(3):307-10.
1995: Zídek Z; Franková D; Otová B
Lack of causal relationship between inducibility/severity of adjuvant arthritis in the rat and disease associated changes in production of nitric oxide by macrophages.
Annals of the rheumatic diseases 1995;54(4):325-7.
1994: Otová B; Zídek Z; Holý A; Votruba I; Franková D
Immunomodulatory properties of 9-(2-phosphonomethoxyethyl)-adenine (PMEA).
Folia biologica 1994;40(4):185-92.
1994: Sladká M; Otová B
Chromosome 11 participation in acute lymphoblastic leukaemia in Sprague-Dawley rats.
Folia biologica 1994;40(4):173-83.
1994: Schramlová J; Otová B; Cerný J; Blazek K
Electron-microscopic demonstration of virus particles in acute lymphoblastic leukaemia in Sprague-Dawley rats.
Folia biologica 1994;40(3):113-8.
1993: Kren V; Otová B; Elleder D; Elleder M; Panczak A; Sladká M
Model of acute graft-vs-host-disease in adult (SHR x BN.lx)F1 rats and its inhibition by adenine analog.
Transplantation proceedings 1993;25(5):2822-3.
1993: Kren V; Otová B; Elleder D; Elleder M; Panczak A; Holý A
Prevention of acute graft-versus-host disease in rats using 9-(2-phosphonomethoxyethyl) adenine (PMEA).
Folia biologica 1993;39(2):78-86.
1993: Bílá V; Otová B; Jelínek R; Sladká M; Mejsnarová B; Holý A; Kren V
Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl) adenine (PMEA).
Folia biologica 1993;39(3):150-61.
1993: Otová B; Sladká M; Blazek K; Schramlová J; Votruba I; Holý A
Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). II. Lymphoblastic leukemia in Sprague-Dawley rats.
Folia biologica 1993;39(3):142-9.
1993: Otová B; Sladká M; Votruba I; Holý A; Kren V
Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). I. Lymphatic leukemia KHP-Lw-I in Lewis rats.
Folia biologica 1993;39(3):136-41.
1993: Otová B; Krenová D; Zídek Z; Holý A; Votruba I; Kren V
Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). III. Rat and mouse carcinomas and sarcomas.
Folia biologica 1993;39(6):311-4.
1992: Otová B; Votruba I; Holý A
Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect.
Acta virologica 1992;36(3):313-9.
1988: Otová B; Kren V; Bílá V; Bukovský A
[Homology of class II antigens of the major histocompatibility complex in humans and rats]
Sborník lékar?ský 1988;90(5):129-32.
1988: Otová B; Kren V; Sladká M; Klír P
Spontaneous acute lymphoblastic leukemia in Sprague-Dawley rats. I. Immunogenetic analysis of four individual leukemias.
Neoplasma 1988;35(3):315-20.
1987: Krenová D; Otová B; Kren V
Antigenic phenotype of LEW rat lymphatic leukemia.
Neoplasma 1987;34(2):139-49.
1987: Otová B; Stefanová I; Horejsí V; Nemec M; Kren V; Viklický V
HLA-DQ1 + DQ3-specific monoclonal antibody cross-reacts with a rat MHC-encoded polymorphic determinant.
Folia biologica 1987;33(6):424-9.
1987: Otová B; Kren V; Bukovský A; Pospíchalová J
The cross-reaction patterns of the MRC OX-3, OX-6, and OX-17 monoclonal antibodies on rat inbred and congenic strains.
Folia biologica 1987;33(5):363-6.
1980: Kren V; Krenová B; Bílá V; Otová B
Questions concerning the significance of a close linkage between morphogenetic (1x) and histocompatibility (H-5) loci in the Norway rat.
Folia morphologica 1980;28(1):24-7.

Sign-in to see more